Watson Wants Lidoderm Suit Stayed For Ruling On FTC Power

Law360, Fort Wayne (February 16, 2017, 4:39 PM EST) -- Watson Laboratories Inc. asked a California federal court Wednesday to pause a renewed pay-for-delay lawsuit by the U.S. Federal Trade Commission over pain relief patch Lidoderm while a different court considers Watson's challenge to the agency’s authority to bring such a suit.

A Pennsylvania federal court is weighing Watson’s request for a ruling on the FTC’s authority to file suits over behavior that occurred in the past, the company said. The outcome of that case would weigh considerably on the agency’s California suit alleging Watson and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.